Predictors of response to intravenous immunoglobulin in patients with dermatomyositis: the ProDERM study

By sjmartinez • February 8, 2025

Charles-Schoeman C, Schessl J, Bata-Csörgő Z, Dimachkie MM, Griger Z, Moiseev S, Oddis CV, Schiopu E, Vencovský J, Clodi E, Levine T, Aggarwal R. Predictors of response to intravenous immunoglobulin in patients with dermatomyositis: the ProDERM study. Rheumatology (Oxford). 2025 Feb 7:keaf070. doi: 10.1093/rheumatology/keaf070. Epub ahead of print. PMID: 39918968.

Tags: Anti-TIF1-γ, autoantibody, autoimmune, cutaneous, Dermatomyositis, Intravenous immunoglobulin, myositis-associated antibodies, myositis-specific antibodies, Publications, Rheumatology

Related Posts

US expert Delphi consensus on the prevention and management of stomatitis in patients treated with datopotamab deruxtecan

Rugo H, Bardia A, Bruno DS, Ernani V, Hamilton E, Heist R, Jhaveri K, Levy B, Lisberg A, O'Shaughnessy J, Sands J, Spira A, Tolaney[...]

The protein deacetylase SIRT2 exerts metabolic control over adaptive Beta cell proliferation

Wortham M, Ramms B, Zeng C, Benthuysen JR, Sai S, Pollow DP, Liu F, Schlichting M, Harrington AR, Liu B, Prakash TP, Pirie EC, Zhu[...]

Serum Levels of Aryl Hydrocarbon Receptor Plasma Agonist Activity Are Reduced in Patients With NMOSD and Correlate With Disease Activity

Tsaktanis T, Ammon L, Lößlein L, Peter A, Vandrey O, Naumann UJ, Behne M, Cook LJ, Levy M, Yeaman MR, Bennett JL, Rothhammer V; Guthy-Jackson[...]